Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    lexatumumab
Show Display Options
Rank Status Study
1 Completed HGS-ETR2 to Treat Children With Solid Tumors
Conditions: Ewing's Sarcoma;   Osteosarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Drug: Lexatumumab alone;   Drug: Lexatumumab in combination;   Drug: Interferon gamma 1b in combination;   Drug: Gamma 1b potential expansion

Indicates status has not been verified in more than two years